Overview
Dai Harada practices practicing medicine in Tokyo, Japan.
Their clinical expertise encompasses Agranulocytosis, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Magnesium Deficiency.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Dai Harada
Is Dai Harada a top-rated expert for Agranulocytosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dai Harada is classified as an Experienced expert for Agranulocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Dai Harada participate in research or clinical trials?
Yes. Dai Harada has published 8 articles and abstracts on conditions like Agranulocytosis. You can view a list of Dai Harada's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AgranulocytosisHarada isExperienced. Learn about Agranulocytosis.
- Magnesium DeficiencyHarada isExperienced. Learn about Magnesium Deficiency.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)